170 related articles for article (PubMed ID: 31130875)
1. Detailed Dissection of UBE3A-Mediated DDI1 Ubiquitination.
Elu N; Osinalde N; Beaskoetxea J; Ramirez J; Lectez B; Aloria K; Rodriguez JA; Arizmendi JM; Mayor U
Front Physiol; 2019; 10():534. PubMed ID: 31130875
[TBL] [Abstract][Full Text] [Related]
2. Quantitative proteomics reveals neuronal ubiquitination of Rngo/Ddi1 and several proteasomal subunits by Ube3a, accounting for the complexity of Angelman syndrome.
Ramirez J; Lectez B; Osinalde N; Sivá M; Elu N; Aloria K; Procházková M; Perez C; Martínez-Hernández J; Barrio R; Šašková KG; Arizmendi JM; Mayor U
Hum Mol Genet; 2018 Jun; 27(11):1955-1971. PubMed ID: 29788202
[TBL] [Abstract][Full Text] [Related]
3. Ube3a, the E3 ubiquitin ligase causing Angelman syndrome and linked to autism, regulates protein homeostasis through the proteasomal shuttle Rpn10.
Lee SY; Ramirez J; Franco M; Lectez B; Gonzalez M; Barrio R; Mayor U
Cell Mol Life Sci; 2014 Jul; 71(14):2747-58. PubMed ID: 24292889
[TBL] [Abstract][Full Text] [Related]
4. Angelman syndrome-associated point mutations in the Zn
Kühnle S; Martínez-Noël G; Leclere F; Hayes SD; Harper JW; Howley PM
J Biol Chem; 2018 Nov; 293(47):18387-18399. PubMed ID: 30257870
[TBL] [Abstract][Full Text] [Related]
5. Angelman syndrome-associated ubiquitin ligase UBE3A/E6AP mutants interfere with the proteolytic activity of the proteasome.
Tomaić V; Banks L
Cell Death Dis; 2015 Jan; 6(1):e1625. PubMed ID: 25633294
[TBL] [Abstract][Full Text] [Related]
6. UBE3A-mediated p18/LAMTOR1 ubiquitination and degradation regulate mTORC1 activity and synaptic plasticity.
Sun J; Liu Y; Jia Y; Hao X; Lin WJ; Tran J; Lynch G; Baudry M; Bi X
Elife; 2018 Jul; 7():. PubMed ID: 30020076
[TBL] [Abstract][Full Text] [Related]
7. Subcellular organization of UBE3A in neurons.
Burette AC; Judson MC; Burette S; Phend KD; Philpot BD; Weinberg RJ
J Comp Neurol; 2017 Feb; 525(2):233-251. PubMed ID: 27339004
[TBL] [Abstract][Full Text] [Related]
8. Angelman Syndrome Protein Ube3a Regulates Synaptic Growth and Endocytosis by Inhibiting BMP Signaling in Drosophila.
Li W; Yao A; Zhi H; Kaur K; Zhu YC; Jia M; Zhao H; Wang Q; Jin S; Zhao G; Xiong ZQ; Zhang YQ
PLoS Genet; 2016 May; 12(5):e1006062. PubMed ID: 27232889
[TBL] [Abstract][Full Text] [Related]
9. Expression of the Rho-GEF Pbl/ECT2 is regulated by the UBE3A E3 ubiquitin ligase.
Reiter LT; Seagroves TN; Bowers M; Bier E
Hum Mol Genet; 2006 Sep; 15(18):2825-35. PubMed ID: 16905559
[TBL] [Abstract][Full Text] [Related]
10. UBE3A-mediated PTPA ubiquitination and degradation regulate PP2A activity and dendritic spine morphology.
Wang J; Lou SS; Wang T; Wu RJ; Li G; Zhao M; Lu B; Li YY; Zhang J; Cheng X; Shen Y; Wang X; Zhu ZC; Li MJ; Takumi T; Yang H; Yu X; Liao L; Xiong ZQ
Proc Natl Acad Sci U S A; 2019 Jun; 116(25):12500-12505. PubMed ID: 31160454
[TBL] [Abstract][Full Text] [Related]
11. The Angelman Syndrome protein Ube3A regulates synapse development by ubiquitinating arc.
Greer PL; Hanayama R; Bloodgood BL; Mardinly AR; Lipton DM; Flavell SW; Kim TK; Griffith EC; Waldon Z; Maehr R; Ploegh HL; Chowdhury S; Worley PF; Steen J; Greenberg ME
Cell; 2010 Mar; 140(5):704-16. PubMed ID: 20211139
[TBL] [Abstract][Full Text] [Related]
12. Human disorders of ubiquitination and proteasomal degradation.
Jiang YH; Beaudet AL
Curr Opin Pediatr; 2004 Aug; 16(4):419-26. PubMed ID: 15273504
[TBL] [Abstract][Full Text] [Related]
13. Impaired Neurite Contact Guidance in Ubiquitin Ligase E3a (Ube3a)-Deficient Hippocampal Neurons on Nanostructured Substrates.
Tonazzini I; Meucci S; Van Woerden GM; Elgersma Y; Cecchini M
Adv Healthc Mater; 2016 Apr; 5(7):850-62. PubMed ID: 26845073
[TBL] [Abstract][Full Text] [Related]
14. UBE3A: An E3 Ubiquitin Ligase With Genome-Wide Impact in Neurodevelopmental Disease.
Lopez SJ; Segal DJ; LaSalle JM
Front Mol Neurosci; 2018; 11():476. PubMed ID: 30686997
[TBL] [Abstract][Full Text] [Related]
15. The HECT E3 Ligase E6AP/UBE3A as a Therapeutic Target in Cancer and Neurological Disorders.
Owais A; Mishra RK; Kiyokawa H
Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32751183
[TBL] [Abstract][Full Text] [Related]
16. Adult
Rotaru DC; van Woerden GM; Wallaard I; Elgersma Y
J Neurosci; 2018 Sep; 38(37):8011-8030. PubMed ID: 30082419
[TBL] [Abstract][Full Text] [Related]
17. Mono-ubiquitination of Rabphilin 3A by UBE3A serves a non-degradative function.
Avagliano Trezza R; Punt AM; Mientjes E; van den Berg M; Zampeta FI; de Graaf IJ; van der Weegen Y; Demmers JAA; Elgersma Y; Distel B
Sci Rep; 2021 Feb; 11(1):3007. PubMed ID: 33542309
[TBL] [Abstract][Full Text] [Related]
18. Activity-Dependent Arc Expression and Homeostatic Synaptic Plasticity Are Altered in Neurons from a Mouse Model of Angelman Syndrome.
Pastuzyn ED; Shepherd JD
Front Mol Neurosci; 2017; 10():234. PubMed ID: 28804447
[TBL] [Abstract][Full Text] [Related]
19. Interlinked destinies: How ubiquitin-proteasome and autophagy systems underpin neurocognitive outcomes.
Yang X; Duckhorn J; Marshall J; Huang YA
Exp Neurol; 2024 Jun; 379():114869. PubMed ID: 38901755
[TBL] [Abstract][Full Text] [Related]
20. Angelman syndrome: advancing the research frontier of neurodevelopmental disorders.
Philpot BD; Thompson CE; Franco L; Williams CA
J Neurodev Disord; 2011 Mar; 3(1):50-6. PubMed ID: 21484597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
